Clicky

Bioton S.A.(BIO)

Description: BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.


Keywords: Biotechnology Pharmaceutical Pharmaceutical Products Diabetes Dietary Supplement Pharmacy In China Insulin Hormones Pharmaceutical Preparations Pharmaceutical Substances

Home Page: www.bioton.pl

ul. Poznanska 12
Ozarów Mazowiecki, 05-850
Poland
Phone: 48 22 721 4000


Officers

Name Title
Mr. Jeremy Launders Pres of the Management Board
Mr. Adam Tomasz Polonek Member of Management Board
Ms. Anna Grabowska Sr. Fin. Mang.
Mr. Michal Deptuch Operations Director
Renata Prokopczyk Chief Accountant
Ms. Kamila Musnicka Director of Legal Department
Ms. Joanna Sadowska HR Director
Mr. Mateusz Patryk Kosecki Head of Biolek Bus. Unit & CEO of Biolek Sp. Z O.O.

Exchange: WAR

Country: PL

Currency: Polish złoty (zł)

Forward PE: 0
Trailing PE: 114.3333
Price-to-Book MRQ: 0.4929
Price-to-Sales TTM: 1.4896
IPO Date:
Fiscal Year End: December
Full Time Employees: 375
Back to stocks